Already positive, the research from Bernstein and its analyst Gunther Zechmann still consider the stock as a Buy opportunity. The target price remains set at EUR 60.
The US analyst firm Bernstein Research has upgraded Bayer to Outperform with a target price of 60 euros. As analyst Gunther Zechmann wrote in a study published on Monday in a review of the quarterly.
Initially Neutral on the company, Bernstein s analyst Gunther Zechmann maintained his recommendation. The target price is unchanged and still at EUR 41.